Showing results (121-130 of 141) with videos related to
Sort By:
Pageof 15
Frontiers in Pharmacology|March 1, 2024
The effectiveness of oral anti-SARS-CoV-2 agents in non-hospitalized COVID-19 patients with nonalcoholic fatty liver disease: a retrospective studyChun-Chi Yang, Ya-Wen Tsai, Su-Hung Wang, et al.Journal of Medical Virology|June 14, 2023
Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID-19Jheng-Yan Wu, Mei-Yuan Liu, Ting-Hui Liu, et al.Chest|April 20, 2025
Clinical Impact of Tirzepatide on Patients With OSA and ObesityJheng-Yan Wu, Chia-Chen Chen, Wan-Ling Tu, et al.Communications Medicine|October 16, 2025
Angiotensin receptor-neprilysin inhibitor treatment in people with chronic obstructive pulmonary disease and heart failureWan-Hsuan Hsu, Bo-Wen Shiau, Jheng-Yan Wu, et al.Journal of Medical Virology|November 27, 2023
Nutritional deficiency anemia and post-acute sequelae in patients with severe acute respiratory syndrome coronavirus 2 infection: A six-month retrospective cohort analysis of 30 892 patientsJheng-Yan Wu, Mei-Yuan Liu, Kuo-Chuan Hung, et al.Clinical Neurology and Neurosurgery|December 31, 2011
Spinal epidural abscess in adults caused by Staphylococcus aureus: clinical characteristics and prognostic factorsPo-Yu Huang, Shu-Feng Chen, Wen-Neng Chang, et al.European Journal of Clinical Nutrition|July 21, 2023
Clinical efficacy of enteral nutrition feeding modalities in critically ill patients: a systematic review and meta-analysis of randomized controlled trialsJheng-Yan Wu, Mei-Yuan Liu, Ting-Hui Liu, et al.Nature Communications|July 2, 2025
The clinical effectiveness of sodium-glucose co-transporter-2 inhibitors on prognosis of patients with chronic obstructive pulmonary disease and diabetesJheng-Yan Wu, Khai-Chi Hu, Mei-Yuan Liu, et al.Expert Review of Anti-Infective Therapy|January 5, 2024
The clinical outcomes and effectiveness of antiviral agents among underweight patients with COVID-19Jheng-Yan Wu, Mei-Yuan Liu, Mei-Chuan Lee, et al.Frontiers in Endocrinology|October 29, 2025
Comparative effectiveness of empagliflozin versus dapagliflozin in adults with metabolic dysfunction-associated steatotic liver diseaseJheng-Yan Wu, Yu-Kuan Tu, Chia-Chih Kuo, et al.Pageof 15